CS

Some Facts on Credit Suisse Shares

Large-cap Financial Services company Credit Suisse has logged a 3.6% change today on a trading volume of 3,705,083. The average volume for the stock is 17,098,431.

Credit Suisse Group AG, together with its subsidiaries, provides various financial services in Switzerland, Europe, the Middle East, Africa, the Americas, and Asia Pacific. Based in Zurich, the company has 51,410 full time employees and a market cap of $10,362,366,976. Credit Suisse currently offers its equity investors a dividend that yields 2.6% per year.

The company is now trading -16.62% away from its average analyst target price of $4.76 per share. The 1 analysts following the stock have set target prices ranging from $4.76 to $4.76, and on average give Credit Suisse a rating of underperform.

Over the last year, CS shares have gone down by -62.9%, which represents a difference of -45.5% when compared to the S&P 500. The stock's 52 week high is $11.04 per share and its 52 week low is $3.7. With its operating margins declining an average -12.5% over the last four years, Credit Suisse may not have a strong enough business to reverse this trend.If you would like a free fundamental analysis of Credit Suisse and other stocks that interest you, subscribe to our free newsletter!

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

ON FOCUS